Virus News and Research

Latest Virus News and Research

Study shows chloroquine does not prevent SARS-CoV-2

More than 600,000 people worldwide have fallen victim to the lung disease COVID-19 so far, which is caused by the SARS coronavirus-2 (SARS-CoV-2).

22 Jul 2020

Scientists isolate potent SARS-CoV-2 neutralizing antibodies from COVID-19 patients

Researchers at Columbia University Irving Medical Center have isolated antibodies from several COVID-19 patients that, to date, are among the most potent in neutralizing the SARS-CoV-2 virus.

22 Jul 2020

Vitamin D could help suppress excessive T cell-mediated lung inflammation in severe COVID-19

As COVID-19 continues to spread over the world scientists continue to seek the reasons for the difference in disease severity from person to person.

22 Jul 2020

Monash University researchers pave way for affordable immunotherapies

Researchers from Monash University’s Institute of Pharmaceutical Sciences are paving the way for accessible and affordable cancer treatment by using powerful nanoscale tools to overcome the high costs and long lead-times associated with one of the world’s newest forms of immunotherapy: CAR-T cell therapy.

22 Jul 2020

Avacta provides update on clinical validation of Adeptrix COVID-19 diagnostic test

Avacta is pleased to announce that it has begun work with the UK government’s CONDOR program to evaluate and clinically validate the COVID-19 laboratory assay.

22 Jul 2020

Avacta provides update on clinical validation of Adeptrix COVID-19 diagnostic test

Avacta is pleased to announce that it has begun work with the UK government’s CONDOR program to evaluate and clinically validate the COVID-19 laboratory assay.

22 Jul 2020

Faster identification and isolation of infected individuals reduce viral transmission

A new analysis of SARS-CoV-2 transmission data in China shows that faster identification and isolation of infected, symptomatic individuals contributed to the shortening of the average serial interval - or the period between the onset of symptoms in successive cases - over time, as fewer opportunities occurred for viral transmission from one infector to more individuals.

22 Jul 2020

Survey: Almost 60% of parents are reluctant to protect their children from HPV

Study results documenting parental hesitancy to begin and complete their child's HPV vaccine series were published in The Lancet Public Health by researchers at The University of Texas Health Science Center at Houston (UTHealth).

22 Jul 2020

Study captures unexpected features of SARS-Cov-2 spike protein

The rod-like spike proteins on the surface of SARS CoV-2 are the tip of the spear of the COVID-19 pandemic.

22 Jul 2020

Racially motivated hate crimes increase in the U.S.

Under the Hate Crime Statistic Act, hate crimes are defined as "crimes that manifest evidence of prejudice based on race, gender and gender identity, religion, disability, sexual orientation, or ethnicity."

22 Jul 2020

LabVantage COVID-19 LIMS solution implemented for onsite workplace health and safety

LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services including purpose-built LIMS solutions that allow labs to go live faster and at a lower total cost, today announced that a Fortune 100 global consumer packaged goods company has deployed the LabVantage COVID-19 LIMS solution to ensure employee health and safety in the workplace.

From LabVantage Solutions 22 Jul 2020

A new sign of COVID-19: a rash in the mouth

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has wreaked havoc across the globe, with more than 14.89 million people infected. Coronavirus disease (COVID-19), caused by SARS-CoV-2, has a string of symptoms that include cough, fever, and difficulty of breathing. As the disease evolved, many patients reported the loss of smell and taste as other accompanying symptoms.

21 Jul 2020

Research focuses on detection of COVID-19 airborne droplets using bioengineered membrane

Detection and analysis of airborne coronavirus droplets using a bioengineered membrane is the focus of exploratory research at the University of Maine and University of Massachusetts Amherst, funded by the National Science Foundation.

21 Jul 2020

Lab-made virus infects cells, interacts with antibodies just like SARS-CoV-2

Airborne and potentially deadly, the virus that causes COVID-19 can only be studied safely under high-level biosafety conditions.

21 Jul 2020

Edible coating made with green tea extract kills norovirus, bacteria

Infusing prepared foods with an edible coating that contains green tea extract may lower consumers' chances of catching the highly contagious norovirus by eating contaminated food, new research suggests.

21 Jul 2020

Ultrasensitive biosensing method could shorten the time for identification of COVID-19

Mechanical engineering associate professor Jiangtao Cheng and electrical and computer engineering assistant professor Wei Zhou have developed an ultrasensitive biosensing method that could dramatically shorten the amount of time required to verify the presence of the COVID-19 virus in a sample.

21 Jul 2020

Mouse model of fatal COVID-19 developed for vaccine and drug testing

Now, a new study published on the preprint server bioRxiv in July 2020 presents an engineered transgenic mouse that reproduces the functional and clinical characteristics of severe human SARS-CoV-2 infection.

21 Jul 2020

Researchers demonstrate the production of viral parts within artificial cells

Scientists searching for better diagnostic tests, drugs or vaccines against a virus must all begin by deciphering the structure of that virus.

21 Jul 2020

Breastfeeding support for new mothers during the COVID-19 pandemic

As the COVID-19 pandemic grips the world, concerns about transmission of the highly infectious causative agent – severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - from mother to the baby are valid.

21 Jul 2020

Pfizer/BioNTech COVID-19 vaccine elicits both neutralizing antibodies and T cell response

A new study published on the preprint server medRxiv by a research group from the U.S. and Germany indicates that a novel BNT162b1 RNA-based vaccine against coronavirus disease (COVID-19) induces functional and proinflammatory T cell responses in almost all participants – marking another landmark achievement for this promising vaccine candidate.

21 Jul 2020

Virus News and Research

Latest Virus News and Research

Study shows chloroquine does not prevent SARS-CoV-2

Scientists isolate potent SARS-CoV-2 neutralizing antibodies from COVID-19 patients

Vitamin D could help suppress excessive T cell-mediated lung inflammation in severe COVID-19

Monash University researchers pave way for affordable immunotherapies

Avacta provides update on clinical validation of Adeptrix COVID-19 diagnostic test

Avacta provides update on clinical validation of Adeptrix COVID-19 diagnostic test

Faster identification and isolation of infected individuals reduce viral transmission

Survey: Almost 60% of parents are reluctant to protect their children from HPV

Study captures unexpected features of SARS-Cov-2 spike protein

Racially motivated hate crimes increase in the U.S.

LabVantage COVID-19 LIMS solution implemented for onsite workplace health and safety

A new sign of COVID-19: a rash in the mouth

Research focuses on detection of COVID-19 airborne droplets using bioengineered membrane

Lab-made virus infects cells, interacts with antibodies just like SARS-CoV-2

Edible coating made with green tea extract kills norovirus, bacteria

Ultrasensitive biosensing method could shorten the time for identification of COVID-19

Mouse model of fatal COVID-19 developed for vaccine and drug testing

Researchers demonstrate the production of viral parts within artificial cells

Breastfeeding support for new mothers during the COVID-19 pandemic

Pfizer/BioNTech COVID-19 vaccine elicits both neutralizing antibodies and T cell response

A new way of characterising biomolecules eBook

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Newsletters you may be interested in